|
|
|
|
|
Definitions and Background |
|
Effects of N2O |
|
Technique |
|
Complications/Precautions |
|
Effects on Systems |
|
Controlling N2O in the Operatory |
|
|
|
|
|
|
|
|
|
|
|
|
|
20% having high fear of dentistry |
|
2/3 of these acquired in early childhood (Milgrom,
JADA, 1988) |
|
25% of adults - fear of injections (Milgrom,
JADA, 1997) |
|
30% somewhat or very nervous, or terrified of
going to the dentist (45 million) (Dionne, JADA, February 1998) |
|
23 million willing to go to the dentist if GA
and CS more readily available. |
|
|
|
|
|
|
1793 - Joseph Priestly invented N2O |
|
Initially used as an anesthetic agent in 1844. |
|
|
|
|
|
|
|
|
|
|
Reduce fear, apprehension, or anxiety |
|
Raise pain reaction threshold |
|
Reduce fatigue |
|
|
|
|
One group treated with behavior management only;
other group with behavior management and N2O. |
|
Dental treatment of highly fearful children is
carried out more successfully with N2O during the first few sessions. |
|
N2O is thus a valuable aid for making highly
fearful children treatable quickly. |
|
|
|
|
When highly anxious children are treated with
nitrous oxide for a number of consecutive sessions, their anxiety remains
significantly lower during a following control period, even without use of
nitrous oxide. |
|
|
|
|
|
|
|
|
|
Analgesia |
|
patient is conscious |
|
reflexes are intact |
|
Delerium |
|
Surgical Anesthesia |
|
Respiratory Paralysis |
|
|
|
|
In analgesia stage, the patient is conscious,
has all vital reflexes intact, can communicate and cooperate with the
dentist, and quickly returns to a normal state following a few minutes of
oxygenation. |
|
|
|
|
Paresthesia - tingling of hands, feet |
|
Vasomotor - warm sensations |
|
Drift - euphoria, pupils centrally fixed,
sensation of floating |
|
Dream - eyes closed but will open in response to
questions, difficulty in speaking, jaw sags open |
|
|
|
|
Ease fears and anxieties |
|
Aid in the treatment of special patients |
|
Increase tolerance for longer appointments |
|
Raise the pain reaction threshold |
|
|
|
|
Control defiant or uncontrolled behavior |
|
Control pain by replacing local anesthesia |
|
Replace poor techniques of behavior management |
|
|
|
|
|
|
The purpose of the present study was to measure
feelings of pleasure by children who were undergoing dental treatment under
nitrous oxide therapy during consecutive treatment sessions, and at a
six-month follow-up visit. |
|
Fifty-two children between the ages of 3 and 5
years (mean age 4.3 +/- 1.06) children, who required two or more operative
treatment visits participated in the study. |
|
It is concluded that the sense of pleasure is
strengthened through the second visit, but that the sense of pleasure and
ability to cope is overwhelmed by the inconvenience of the dental treatment
at the third visit. |
|
|
|
|
|
|
Reminding child continuously to hold mouth open |
|
No response to questions |
|
Agitation |
|
Sweating |
|
Nausea |
|
Unconsciousness |
|
|
|
|
with lengthy administration (> 30 min.). |
|
|
|
|
Rapid |
|
Primarily through the lungs |
|
Small amount through skin, sweat glands, urine,
and intestinal gas |
|
|
|
|
High outpouring of N2O |
|
Dilutes available oxygen in lungs |
|
|
|
|
|
|
Portable oxygen tank |
|
Delivery system that delivers a maximum of 80%
N2O |
|
Medical history |
|
Physical evaluation ("...vital signs such
as pulse, blood pressure, respirations, temperature and weight..." |
|
Oral pharyngeal airways available |
|
Emergency drugs |
|
|
|
|
Patient in reclined position |
|
Use TSD |
|
Describe sensations in advance |
|
|
|
|
ASA I - A normal healthy patient. (ASA =
American Society of Anesthesiologists) |
|
ASA II - A patient with mild systemic disease. |
|
ASA III - A patient with severe systemic
disease. |
|
ASA IV - A patient with severe systemic disease
that is a constant threat to life. |
|
ASA V - A moribund patient who is not expected
to survive without the operation. |
|
ASA VI - A declared brain-dead patient whose
organs are being removed for donor purposes. |
|
E - Emergency operation of any variety (used to
modify one of the above classifications, i.e., ASA III-E). |
|
|
|
|
|
|
Medical history & vital signs |
|
5 - 6 liters O2 |
|
Increase N2O gradually; watch for stages of
analgesia |
|
Maintenance about 20 - 40% |
|
Reduce N2O with long procedures |
|
Record N2O levels in the chart |
|
3 - 5 minute O2 flush |
|
Rapid induction (surge) technique |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vomiting - due to: |
|
overdosage |
|
prolonged administration |
|
pre-existing GI infection, influenza |
|
history of motion sickness or vomiting (use
anti-emetic) |
|
impurities in the delivery system (rare) |
|
If vomiting occurs, turn patient to the side and
use HVE |
|
Prevent vomiting by close observation of patient |
|
|
|
|
Complications/Precautions |
|
|
|
|
Estimated 40% of asthmatic attacks are
psychologically induced (Bennet, 1984) |
|
Clinically significant decrease in lung function
in 15% of pediatric patients but couldn’t predict who would have this
decrease (Mathew, JADA, Aug 1998) |
|
|
|
|
|
Mild rhinitis or colds are not absolute
contraindications |
|
Contraindicated in patients with a depressed
respiratory system |
|
chronic emphysema |
|
tuberculosis |
|
multiple sclerosis |
|
remember, N2O will potentiate drugs that depress
the respiratory system |
|
|
|
|
Contraindicated in patients with blocked
eustachian tube, pneumothorax, pneumoperitoneum, and pneumopericardium |
|
Contraindicated in the first trimester of
pregnancy |
|
|
|
|
|
Other possible contraindications: |
|
severe cardiac disease |
|
hyperthyroidism |
|
uncontrolled diabetes |
|
sickle cell anemia |
|
severe asthmatic conditions |
|
|
|
|
|
|
|
CNS - primary system effected by N2O |
|
Respiratory |
|
respiratory rate increase |
|
decrease tidal volume |
|
N2O potentiates respiratory depression with
concommitant use of narcotics, barbiturates, or other sedatives |
|
|
|
|
|
Cardiovascular |
|
normally, no meaningful changes in heart rate or
pressure |
|
myocardial depression with cardiac
decompensation (congestive heart failure) |
|
patients with ischemic heart disease without decompensation may benefit from N2O |
|
|
|
|
|
|
|
|
Reproductive |
|
Hematologic |
|
Immunological |
|
Neurological |
|
Liver |
|
Kidney |
|
|
|
|
Loss of concentration |
|
Numbness and paresthesia |
|
Ataxia |
|
Loss of bowel sphincter control |
|
Loss of bladder control |
|
Impotence |
|
|
|
|
|
|
|
|
1967 (Vaisman) - report showing increased
incidence of spontaneous abortion among female Russian anesthesiologists |
|
1980 (Cohen, et al) - report showing increased
spontaneous abortion rates (2.3) for DAs and unexposed wives of DDSs who
used N2O in their practices; also higher rates of liver, kidney and
neurological disease |
|
1992 (Rowland, et al.) - demonstrated reduced
fertility among female DAs exposed to ambient levels of unscavenged N2O for
longer than five hours per week; the concentration and length of exposure
that produce any of these effects remain undocumented. |
|
|
|
|
|
|
|
|
1977 - the National Institute of Occupational
Safety and Health issued an Alert, cautioning health professionals not to
exceed the agency's recommended exposure level of 25 parts per million. |
|
July 1980 - JADA, Ellis Cohen, M.D., published a
study titled "Occupational Disease in Dentistry and Chronic Exposure
to Trace Anesthetic Gases." |
|
1980 - the ADA Council on Dental Materials,
Instruments and Equipment recommended that dentists equip their offices
with scavenging systems. |
|
1994 - NIOSH reiterated its cautionary that
exposure to nitrous oxide be limited to 25 ppm. |
|
1995 - CSA convened an expert panel to review
the scientific literature on nitrous oxide and determine what might be an
appropriate, or safe, level. While the group never reached a consensus,
they did agree that the NIOSH recommendation appeared unreasonably low. The
panel then issued its recommendations, published in 1997, for minimizing
exposure in the dental office. |
|
|
|
|
|
|
In 1997, the ADA councils on Scientific Affairs
and Dental Practice brought together a panel of researchers and asked them
how dentists might best control nitrous oxide concentrations in their
offices. |
|
After studying the scientific literature on
nitrous oxide, the panelists issued 11 recommendations: |
|
|
|
|
|
|
|
The dental office should have a properly
installed nitrous oxide delivery system. This includes appropriate scavenging
equipment with a readily visible and accurate flow meter (or equivalent
measuring device), a vacuum pump with the capacity for up to 45 liters of
air per minute per workstation, and a variety of sizes of masks to ensure
proper fit for individual patients. |
|
The vacuum exhaust and ventilation exhaust
should be vented to the outside (for example, through the vacuum system)
and not in close proximity to fresh-air intake vents. |
|
The general ventilation should provide good room
air mixing. |
|
|
|
|
|
|
|
Each time the nitrous oxide machine is first
turned on and every time a gas cylinder is changed, the pressure
connections should be tested for leaks. High-pressure line connections
should be tested for leaks on a quarterly basis. A soap solution can be
used for testing. Or, alternatively, a portable infrared spectrophotometer
can be used to diagnose an insidious leak. |
|
Prior to first daily use, all nitrous oxide
equipment (reservoir bag, tubings, mask, connectors) should be inspected
for worn parts, cracks, holes or tears. Replace as necessary. |
|
The mask may then be connected to the tubing and
the vacuum pump turned on. All appropriate flow rates (that is, up to 45
L/min. or per manufacturer's recommendations) should be verified. |
|
|
|
|
|
|
|
A properly sized mask should be selected and
placed on the patient — and a good comfortable fit ensured. The reservoir
(breathing) bag should not be over- or underinflated while the patient is
breathing oxygen (before administering nitrous oxide). |
|
The patient should be encouraged to minimize
talking and breathing through his or her mouth while the mask is in place. |
|
During administration, the reservoir bag should
be periodically inspected for changes in tidal volume and the vacuum flow
rate should be verified. |
|
|
|
|
|
|
|
Upon completing administration, 100 percent
oxygen should be delivered to the patient for five minutes before removing
the mask. In this way, both the patient and the system will be purged of
residual nitrous oxide. Do not use oxygen flush. |
|
Periodic (semiannual interval is suggested)
personal sampling of dental personnel, with emphasis to chairside personnel
exposed to nitrous oxide, should be conducted (for example, use of
diffusive sampler [dosimeters] or infrared spectrophotometer). |
|
|
|
|
|
|
|
|
|
|
|
|
Engineering controls |
|
Inspection |
|
equipment for wear, cracks, tears |
|
test connections |
|
Scavenging system |
|
no system currently accepted by ADA |
|
flow rate of 45 L/min vacuum rate |
|
|
|
|
|
Ventilation |
|
Fresh air inlets - ceiling |
|
Return air vents - floor level |
|
Location of ventilation system exhaust |
|
Air exchange rate (>10/hr) |
|
|
|
|
|
|
|
Factors of scavenging effectiveness |
|
auxilliary evacuation |
|
rate of evacuation of scavenging device |
|
operatory ventilation |
|
use of air sweep fans |
|
reduced concentration of delivered N2O |
|
poor patient behavior |
|
certain procedures (local anesthesia) |
|
improper administration |
|
loose connections |
|
|
|
|
|
|
|
|
|